Cargando…

How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis

INTRODUCTION: Adaptive designs offer a flexible approach, allowing changes to a trial based on examinations of the data as it progresses. Adaptive clinical trials are becoming a popular choice, as the prudent use of finite research budgets and accurate decision-making are priorities for healthcare p...

Descripción completa

Detalles Bibliográficos
Autores principales: Flight, Laura, Julious, Steven, Brennan, Alan, Todd, Susan, Hind, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060544/
https://www.ncbi.nlm.nih.gov/pubmed/32143728
http://dx.doi.org/10.1186/s13063-020-4137-2
_version_ 1783504253326721024
author Flight, Laura
Julious, Steven
Brennan, Alan
Todd, Susan
Hind, Daniel
author_facet Flight, Laura
Julious, Steven
Brennan, Alan
Todd, Susan
Hind, Daniel
author_sort Flight, Laura
collection PubMed
description INTRODUCTION: Adaptive designs offer a flexible approach, allowing changes to a trial based on examinations of the data as it progresses. Adaptive clinical trials are becoming a popular choice, as the prudent use of finite research budgets and accurate decision-making are priorities for healthcare providers around the world. The methods of health economics, which aim to maximise the health gained for money spent, could be incorporated into the design and analysis of adaptive clinical trials to make them more efficient. We aimed to understand the perspectives of stakeholders in health technology assessments to inform recommendations for the use of health economics in adaptive clinical trials. METHODS: A qualitative study explored the attitudes of key stakeholders—including researchers, decision-makers and members of the public—towards the use of health economics in the design and analysis of adaptive clinical trials. Data were collected using interviews and focus groups (29 participants). A framework analysis was used to identify themes in the transcripts. RESULTS: It was considered that answering the clinical research question should be the priority in a clinical trial, notwithstanding the importance of cost-effectiveness for decision-making. Concerns raised by participants included handling the volatile nature of cost data at interim analyses; implementing this approach in global trials; resourcing adaptive trials which are designed and adapted based on health economic outcomes; and training stakeholders in these methods so that they can be implemented and appropriately interpreted. CONCLUSION: The use of health economics in the design and analysis of adaptive clinical trials has the potential to increase the efficiency of health technology assessments worldwide. Recommendations are made concerning the development of methods allowing the use of health economics in adaptive clinical trials, and suggestions are given to facilitate their implementation in practice.
format Online
Article
Text
id pubmed-7060544
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70605442020-03-12 How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis Flight, Laura Julious, Steven Brennan, Alan Todd, Susan Hind, Daniel Trials Research INTRODUCTION: Adaptive designs offer a flexible approach, allowing changes to a trial based on examinations of the data as it progresses. Adaptive clinical trials are becoming a popular choice, as the prudent use of finite research budgets and accurate decision-making are priorities for healthcare providers around the world. The methods of health economics, which aim to maximise the health gained for money spent, could be incorporated into the design and analysis of adaptive clinical trials to make them more efficient. We aimed to understand the perspectives of stakeholders in health technology assessments to inform recommendations for the use of health economics in adaptive clinical trials. METHODS: A qualitative study explored the attitudes of key stakeholders—including researchers, decision-makers and members of the public—towards the use of health economics in the design and analysis of adaptive clinical trials. Data were collected using interviews and focus groups (29 participants). A framework analysis was used to identify themes in the transcripts. RESULTS: It was considered that answering the clinical research question should be the priority in a clinical trial, notwithstanding the importance of cost-effectiveness for decision-making. Concerns raised by participants included handling the volatile nature of cost data at interim analyses; implementing this approach in global trials; resourcing adaptive trials which are designed and adapted based on health economic outcomes; and training stakeholders in these methods so that they can be implemented and appropriately interpreted. CONCLUSION: The use of health economics in the design and analysis of adaptive clinical trials has the potential to increase the efficiency of health technology assessments worldwide. Recommendations are made concerning the development of methods allowing the use of health economics in adaptive clinical trials, and suggestions are given to facilitate their implementation in practice. BioMed Central 2020-03-06 /pmc/articles/PMC7060544/ /pubmed/32143728 http://dx.doi.org/10.1186/s13063-020-4137-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Flight, Laura
Julious, Steven
Brennan, Alan
Todd, Susan
Hind, Daniel
How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis
title How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis
title_full How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis
title_fullStr How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis
title_full_unstemmed How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis
title_short How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis
title_sort how can health economics be used in the design and analysis of adaptive clinical trials? a qualitative analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060544/
https://www.ncbi.nlm.nih.gov/pubmed/32143728
http://dx.doi.org/10.1186/s13063-020-4137-2
work_keys_str_mv AT flightlaura howcanhealtheconomicsbeusedinthedesignandanalysisofadaptiveclinicaltrialsaqualitativeanalysis
AT julioussteven howcanhealtheconomicsbeusedinthedesignandanalysisofadaptiveclinicaltrialsaqualitativeanalysis
AT brennanalan howcanhealtheconomicsbeusedinthedesignandanalysisofadaptiveclinicaltrialsaqualitativeanalysis
AT toddsusan howcanhealtheconomicsbeusedinthedesignandanalysisofadaptiveclinicaltrialsaqualitativeanalysis
AT hinddaniel howcanhealtheconomicsbeusedinthedesignandanalysisofadaptiveclinicaltrialsaqualitativeanalysis